Replies to post #328662 on Amarin Corp Plc (AMRN)

[Mr1979]

Bill

They’ve got a number of patents which is good. However, aren’t the patents utility and value limited to their ability to be used in a medical setting ? As in Amarin needs to run long expensive trials to provide evidence of efficacy for Vascepa to treat not only CVD but also the list of patented treatments on their list of IP.

I mention it as not to get too excited about a patent until there’s proof in the results that this is a potential new indication. Which takes years and money to fund the trials.

[CaptBeer]

This is just an old application. Not yet approved.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=15703782&OS=15703782&RS=15703782